Compare GSK plc (GSK) vs Southwest Airlines Co (LUV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GSK plc vs Southwest Airlines Co — how do they compare? GSK plc trades at $51.15 (market cap $102.60B), while Southwest Airlines Co trades at $45.6 (market cap $22.27B). The key difference: GSK plc is far larger — about 4.6× Southwest Airlines Co's market cap, and GSK plc pays the higher dividend (3.57%). Which is the better fit depends on your goals.
| GSK | LUV | |
|---|---|---|
Market Cap | $102.60B | $22.27B |
Sector | Health | Industrials |
52-Week High | $61.18 | $54.80 |
52-Week Low | $38.22 | $29.67 |
Enterprise Value | $123.04B | $25.37B |
Dividend Yield | 3.57% | 1.58% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GSK trades at $50.27, down 3.62% today, with a bearish technical signal but strong fundamentals including a P/E of 16.02 and net income margin of 14.52%. Recent quarters show earnings beats, and the company announced a $2.52 billion cost-saving plan to boost its drug pipeline. Cash flow from operations remains robust at $7.74 billion for 2025.
The outlook is mixed: analyst consensus leans hold (55.18%) amid valuation concerns, but revenue growth and pipeline investments support long-term potential. Key risks include competitive pressures and regulatory uncertainty, as highlighted by recent news on vaccine policies. The stock offers a dividend yield with payments scheduled through 2026.
Southwest Airlines (LUV) trades at $45.06, up 0.36% with mixed technical signals showing bearish moving averages but neutral oscillators. The company reported strong Q2 2026 earnings with $0.94 EPS beating expectations by 84%, while Q1 missed estimates. Revenue growth continues with 2026 projections at $30.1B, though net margins remain thin at 2.78%. Recent board appointments and business travel initiatives signal strategic focus on premium segments.
LUV presents a value opportunity with attractive P/S (0.79) and dividend yield, but faces headwinds from fuel cost volatility and competitive pressures. Analyst consensus targets $53.86 (20% upside) with mixed ratings. The stock's outlook hinges on sustained travel demand and effective cost management amid industry challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About GSK plc
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, cancer, and antiviral, as well as vaccines. GSK uses joint ventures to gain additional scale in certain markets like HIV.
Read more on GSK →About Southwest Airlines Co
Southwest Airlines is the largest domestic carrier in the United States, as measured by the number of originating passengers boarded. Southwest operates over 700 aircraft in an all-Boeing 737 fleet. Despite expanding into longer routes and business travel, the airline still specializes in short-haul leisure flights, using a point-to-point network. Southwest operates a low-cost carrier business model.
Read more on LUV →
